Sustainable

business

solutions

Learn more at Pharmapack

booth B72, Feb 5-6 Paris, France

NOLATO GOES GREEN

Sustainable and Renewable packaging materials

Sustainability has always been an integral part of the strategy for the Nolato group. Our aim is to be in the lead and we are constantly seeking new sustainable business solutions and to contribute to a better environment. Nolato is now introducing bio-based Polyet-hylene packaging produced from sugarcane – renewable, sustainable and ECO friendly!

Several product ranges from Nolato Jaycare and Nolato Cerbo have been validated with the alternative “green” Polyethylene and all product properties - mechanical, functional, recycling - are identical to those of petrochemical resins. 
The difference is in the carbon footprint, which is significantly lower for bioplastics in comparison with oil based raw materials.
Contact us and we will show you our new Green product alternatives to you.

Product Performance

PROPERTY

REQUIREMENT IN STANDARD1)

NORMAL POLYMER

SUSTAINABLE POLYMER

Tightness WVP2)avg

Tightness WVPmax

Light transmission3)

30 mg/day/L 
20 mg/day/L 
<10% for 290-450 nm

<3

<4

<10

<3

<4

<10

Notes:

1) According to USP 671 standards

2) Tightness - average values of Cerbo Classic 200ml with SC Light 42 cap and Cerbo Threasy

3) Light transmission - average values of Cerbo Classic (200ml) and Cerbo Threasy bottles

For further information, contact:
E-mail: nolatocerbo@nolato.com  /  www.nolato.com/pharma-packaging

Go to article: Home | The path of yeast resistanceGo to article: NSFGo to article: EditorialGo to article: ContentsGo to article: NewsGo to article: Emirates SkyCargoGo to article: The pharma industry briefingGo to article: A resolution for the new decade: resolve the US opioid crisisGo to article: Eurofins CDMOGo to article: Precision medicine: what barriers remain?Go to article: Can recyclable packaging turn the pharma industry green?Go to article: Phoenix Company InsightGo to article: PhoenixGo to article: Vertex’s Trikafta: treating the genetic basis of cystic fibrosis Go to article: Accurate Biometrics Company Insight Go to article: Accurate BiometricsGo to article: Q&A: talking innovation with the Association for the Cannabinoid IndustryGo to article: Yeast of burden: how to develop better antifungal drugsGo to article: Loose lips bring risks: protecting pharma against leaks and fraud Go to article: Why are patients struggling to access life-saving immune globulin?Go to article: MimotopesGo to article: Deals in brief powered by GlobalDataGo to article: Nolato Company Insight Go to article: NolatoGo to article: The key list powered by GlobalDataGo to article: EventsGo to article: Next issue